Search results
Results from the WOW.Com Content Network
Treatment for secondary juvenile osteoporosis focuses on treating any underlying disorder. [3] Treatment of Juvenile osteoporosis can also include maintaining a healthy lifestyle. This is accomplished by exercising, keeping a balanced diet of proper food and drinks, as well as keeping your body full of the necessary vitamins.
Clinical guidelines provide treatment recommendations dependent on the clinical characteristics. [24] The treatment of most types of juvenile arthritis include medications, physical therapy, splints and in severe cases surgery. [12] The type and intensity of the treatment is largely based upon the subtype and severity of damage of the disease. [6]
Medical algorithms based on best practice can assist everyone involved in delivery of standardized treatment via a wide range of clinical care providers. Many are presented as protocols and it is a key task in training to ensure people step outside the protocol when necessary.
A pathologic fracture is a bone fracture caused by weakness of the bone structure that leads to decrease mechanical resistance to normal mechanical loads. [1] This process is most commonly due to osteoporosis, but may also be due to other pathologies such as cancer, infection (such as osteomyelitis), inherited bone disorders, or a bone cyst.
Juvenile, in this context, refers to disease onset before 16 years of age, while idiopathic refers to a condition with no defined cause, and arthritis is inflammation within the joint. [ 4 ] JIA is an autoimmune, noninfective, inflammatory joint disease, the cause of which remains poorly understood.
Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. [21] [22] The most common side effects are joint and muscle pain in the arms or legs. [23]
Systemic-onset juvenile idiopathic arthritis (sJIA), also known as Still disease, Still's disease, and systemic juvenile idiopathic arthritis, is a subtype of juvenile idiopathic arthritis (JIA) that is distinguished by arthritis, a characteristic erythematous skin rash, and remitting fever. [5]
Treatment modalities are based on scientific research, currently, the practice of rheumatology is largely evidence-based. [2] Rheumatologists treat arthritis, autoimmune diseases, pain disorders affecting joints, and osteoporosis. [3]